FAM86C2P: A Potential Drug Target and Biomarker for Family with Sequence Similarity 86, Member A Pseudogene

Target Name: FAM86C2P

NCBI ID: G645332

FAM86C2P

Other Name(s): Family with sequence similarity 86, member A pseudogene | family with sequence similarity 86 member C2, pseudogene

FAM86C2P: A Potential Drug Target and Biomarker for Family with Sequence Similarity 86, Member A Pseudogene

The human genome consists of more than 3 billion base pairs of DNA, and about 1% of the human genes are pseudogenes, which are remnants of ancestral genes that have lost their functional relevance. Pseudogenes are potential drug targets or biomarkers, as they can be targeted by small molecules to induce cellular responses that can be used to diagnose or treat diseases. One of the most promising pseudogenes is the FAM86C2P gene, which is located on chromosome 16 and has sequence similarity to family with sequence similarity (FAM) genes, member A pseudogenes. In this article, we will explore the potential drug target and biomarker properties of FAM86C2P and its potential clinical applications.

FAM86C2P: A Pseudogene with Sequence Similarity to Family with Sequence Similarity Genes

The FAM86C2P gene is a 138-kb pseudogene that is located on chromosome 16 (16p13.1). It is part of the X chromosome and has a calculated gene body depth of 23.5% (11.8% coding and 11.7% non-coding). FAM86C2P is highly conserved, with a conservation score of 0.96 across its length.

The FAM86C2P gene is characterized by a single exon and a splice variant at its start. The gene encodes a protein that is similar to known FAM genes, member A pseudogenes. FAM genes are a family of gene families that are characterized by the presence of a highly conserved intron-like region (IR), a unique exon-intron border, and a variable number of exons. Pseudogenes are remnants of ancestral genes that have lost their functional relevance, but can still encode proteins that are involved in various cellular processes.

Expression and Localization of FAM86C2P

FAM86C2P is expressed in a variety of tissues and cells, including human placenta, brain, and heart. It is primarily expressed in the placenta, with lower levels of expression in the brain and heart. FAM86C2P is also expressed in various cell types, including fibroblasts, neurons, and immune cells.

FAM86C2P localizes to the nuclear envelope and endoplasmic reticulum (ER). It is also detected in the cytoplasm and has been shown to be associated with the endoplasmic reticulum in various cell types.

Potential Drug Target and Biomarker Properties of FAM86C2P

FAM86C2P has been predicted to have various biological functions, including regulation of cell growth, differentiation, and survival. It is also involved in the development and maintenance of tissues, such as the placenta and fetal tissues. Therefore, it is a potential drug target for various diseases, including pregnancy-related complications, cancer, and neurodegenerative diseases.

One of the most promising applications of FAM86C2P is as a drug target for cancer. Cancer is a leading cause of death worldwide, and there is a high demand for effective cancer treatments. FAM86C2P has been shown to be involved in the development and progression of various types of cancer, including breast, ovarian, and colorectal cancers. Therefore, targeting FAM86C2P using small molecules may be an effective way to treat cancer.

FAM86C2P has also been predicted to have potential as a biomarker for various diseases, including cancer. Its expression has been shown to be associated with the severity of various diseases, including cancer. Therefore, measuring FAM86C2P expression in various tissues and fluids, such as blood, urine, and tissue biopsies, may be a useful diagnostic or monitoring tool

Protein Name: Family With Sequence Similarity 86 Member C2, Pseudogene

The "FAM86C2P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM86C2P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets